TrianglePUBLICATIONS · 34649088
Treatment outcome with a selective RET tyrosine kinase inhibitor selpercatinib in children with multiple endocrine neoplasia type 2 and advanced medullary thyroid carcinoma.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Eur J Cancer
- Publication date
- 2021 Nov
- First author
- Shankar A
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Shankar A
- type
- Author
- name
- Kurzawinski T
- type
- Author
- name
- Ross E
- type
- Author
- name
- Stoneham S
- type
- Author
- name
- Beale T
- type
- Author
- name
- Proctor I
- type
- Author
- name
- Hulse T
- type
- Author
- name
- Simpson K
- type
- Author
- name
- Gaze MN
- type
- Author
- name
- Cattaneo E
- type
- Author
- name
- Gevers E
- type
- Author
- name
- Marshall L
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Shankar A
- type
- Author
- name
- Kurzawinski T
- type
- Author
- name
- Ross E
- type
- Author
- name
- Stoneham S
- type
- Author
- name
- Beale T
- type
- Author
- name
- Proctor I
- type
- Author
- name
- Hulse T
- type
- Author
- name
- Simpson K
- type
- Author
- name
- Gaze MN
- type
- Author
- name
- Cattaneo E
- type
- Author
- name
- Gevers E
- type
- Author
- name
- Marshall L
- type
- Author
- bibliography ids
- nci-bib-28a657c81697e1b9b50c6171
- book metadata
- content sha256
- df9f90624be0db416cff39445773c78dc38e255a2dec6f9e109a91093c101fb5
- document type
- citation
- dois
- 10.1016/j.ejca.2021.09.012
- electronic publication date
- display
- 2021 Oct 11
- precision
- day
- year
- 2021
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:34649088
- immutable id
- pubmed:34649088@df9f90624be0db416cff39445773c78dc38e255a2dec6f9e109a91093c101fb5
- journal
- abbreviation
- Eur J Cancer
- issn electronic
- 1879-0852
- issn print
- 0959-8049
- issue
- Source null
- name
- European journal of cancer (Oxford, England : 1990)
- nlm unique id
- 9005373
- pages
- 38-46
- volume
- 158
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 34649088
- provenance
- batch id
- 192b6392c165c6b06274
- provider
- NCBI PubMed ESummary
- record sha256
- f7977ac8b876b7b29249b24d390eb4fb71221a390bebcba18eac40cf82a9f43e
- response sha256
- 7d81e9fb11ee99e6ad4116aecd61ba71cd6bf76f2a8f8f6d15c5c85e9c6c56b4
- retrieved at
- 2026-09-09T23:48:02.713075+00:00
- publication date
- display
- 2021 Nov
- precision
- month
- year
- 2021
- publication types
- Journal Article
- record status
- PubMed
- schema version
- 1.0
- title
- Treatment outcome with a selective RET tyrosine kinase inhibitor selpercatinib in children with multiple endocrine neoplasia type 2 and advanced medullary thyroid carcinoma.
Preserved source evidence · Not medical advice